Lung Cancer
3,087
432
567
1,522
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
405 trials with published results (13%)
Research Maturity
1522 completed trials (49% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.1%
281 terminated out of 3087 trials
84.4%
-2.1% vs benchmark
7%
219 trials in Phase 3/4
27%
405 of 1522 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1522 completed trials
Clinical Trials (3087)
REStoring lymphoCytes Using NKTR-255* After chemoradiothErapy in Solid Tumors (RESCUE)
Annual Brain MRI Surveillance for Detection of Brain Metastasis in Patients With Lung Cancer
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
PHASE 1b STUDY OF HS-20122 COMBINED THERAPY IN NSCLC
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
Evaluation for NCI Surgery Branch Clinical Research Protocols
Genetic Susceptibility to Lung Cancer in Never Smokers
Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer
Association of Bone and Metabolic Parameters With Overall Survival in Patients With Bone Metastases From Adenocarcinoma Lung Cancer (POUMOS)
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
Evaluation of the Safety and Efficacy of a Wideband Electric Pulse Tumor Ablation System for Malignant Pulmonary Nodules
Olomorasib + Pembrolizumab KRAS G12C Mutant, PD-L1 TPS 1-49% Locally Advanced or Metastatic NSCLC
Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigating Radiation-response and Toxicity
Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer
Screening for Lung Cancer in Subjects With Family History of Lung Cancer
Comparing Palliative Radiotherapy With or Without Carboplatin
A Trial to Compare Robotic Assisted Bronchoscopy Ion's Clinical Utility for Peripheral Lung Nodule Access and Diagnosis to ENB
Safety & Efficacy of Consolidative Hypofractionated Radiation Therapy for Boosting Residual Lung Cancer With Durvalumab
Implementing Low-dose ct Lung Cancer Screening in France.